Literature DB >> 15380779

Host subversion by formation of intracellular bacterial communities in the urinary tract.

Gregory G Anderson1, Steven M Martin, Scott J Hultgren.   

Abstract

Urinary tract infections pose a serious health threat with respect to antibiotic resistance and high recurrence rates. While the host robustly responds to bacterial infiltration into the bladder, uropathogenic Escherichia coli can survive the onslaught to persist for months after initially infecting. To accomplish this feat, uropathogenic E. coli forms intracellular bacterial communities, with many biofilm-like properties, within the bladder epithelium. These communities may allow bacteria to subvert host defenses and form a persistent reservoir in the bladder.

Entities:  

Mesh:

Year:  2004        PMID: 15380779     DOI: 10.1016/j.micinf.2004.05.023

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  28 in total

Review 1.  Host-pathogen interactions in urinary tract infection.

Authors:  Greta R Nielubowicz; Harry L T Mobley
Journal:  Nat Rev Urol       Date:  2010-07-20       Impact factor: 14.432

Review 2.  [Single-use intermittent catheterisation].

Authors:  U Grigoleit; J Pannek; M Stöhrer
Journal:  Urologe A       Date:  2006-02       Impact factor: 0.639

3.  Urinary bactericidal activity of extended-release ciprofloxacin (1,000 milligrams) versus levofloxacin (500 milligrams) in healthy volunteers receiving a single oral dose.

Authors:  Florian M E Wagenlehner; Martina Kinzig-Schippers; Uwe Tischmeyer; Christine Wagenlehner; Fritz Sörgel; Kurt G Naber
Journal:  Antimicrob Agents Chemother       Date:  2006-09-18       Impact factor: 5.191

4.  Role of the rapA gene in controlling antibiotic resistance of Escherichia coli biofilms.

Authors:  S V Lynch; L Dixon; M R Benoit; E L Brodie; M Keyhan; P Hu; D F Ackerley; G L Andersen; A Matin
Journal:  Antimicrob Agents Chemother       Date:  2007-07-30       Impact factor: 5.191

5.  Enterococcus faecalis infection activates phosphatidylinositol 3-kinase signaling to block apoptotic cell death in macrophages.

Authors:  Jun Zou; Nathan Shankar
Journal:  Infect Immun       Date:  2014-09-29       Impact factor: 3.441

Review 6.  Updates on urinary tract infections in kidney transplantation.

Authors:  Marco Fiorentino; Francesco Pesce; Antonio Schena; Simona Simone; Giuseppe Castellano; Loreto Gesualdo
Journal:  J Nephrol       Date:  2019-01-28       Impact factor: 3.902

Review 7.  Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era.

Authors:  Maria Kostakioti; Maria Hadjifrangiskou; Scott J Hultgren
Journal:  Cold Spring Harb Perspect Med       Date:  2013-04-01       Impact factor: 6.915

8.  Recurrent urinary tract infections in healthy and nonpregnant women.

Authors:  Matthew Glover; Cristiano G Moreira; Vanessa Sperandio; Philippe Zimmern
Journal:  Urol Sci       Date:  2014-03

Review 9.  Inflammasomes in the urinary tract: a disease-based review.

Authors:  J Todd Purves; F Monty Hughes
Journal:  Am J Physiol Renal Physiol       Date:  2016-05-11

10.  High-throughput identification of chemical inhibitors of E. coli Group 2 capsule biogenesis as anti-virulence agents.

Authors:  Carlos C Goller; Patrick C Seed
Journal:  PLoS One       Date:  2010-07-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.